(Q40131728)

English

A doxycycline-inducible urokinase receptor (uPAR) upregulates uPAR activities including resistance to anoikis in human prostate cancer cell lines

scientific article published on 17 May 2007

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

17 September 2017

A doxycycline-inducible urokinase receptor (uPAR) upregulates uPAR activities including resistance to anoikis in human prostate cancer cell lines (English)

1 reference

Europe PubMed Central

PMC publication ID

17 September 2017

1 reference

based on heuristic

inferred from title

author name string

Mohammad Hasanuzzaman

1

1 reference

Europe PubMed Central

PMC publication ID

17 September 2017

Robert Kutner

2

1 reference

Europe PubMed Central

PMC publication ID

17 September 2017

Siamak Agha-Mohammadi

3

1 reference

Europe PubMed Central

PMC publication ID

17 September 2017

Jakob Reiser

4

1 reference

Europe PubMed Central

PMC publication ID

17 September 2017

Inder Sehgal

5

1 reference

Europe PubMed Central

PMC publication ID

17 September 2017

publication date

17 May 2007

1 reference

Europe PubMed Central

PMC publication ID

17 September 2017

Molecular Cancer

1 reference

Europe PubMed Central

PMC publication ID

17 September 2017

6

1 reference

Europe PubMed Central

PMC publication ID

17 September 2017

34

1 reference

Europe PubMed Central

PMC publication ID

17 September 2017

Structural basis of interaction between urokinase-type plasminogen activator and its receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1885813

22 September 2017

Urokinase signaling through its receptor protects against anoikis by increasing BCL-xL expression levels

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1885813

22 September 2017

RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1885813

22 September 2017

Acquisition of anoikis resistance in human osteosarcoma cells does not alter sensitivity to chemotherapeutic agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1885813

22 September 2017

Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1885813

22 September 2017

The urokinase plasminogen activator and its receptor: role in cell growth and apoptosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1885813

22 September 2017

Effects of blocking urokinase receptor signaling by antisense oligonucleotides in a mouse model of experimental prostate cancer bone metastases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1885813

22 September 2017

Tight control of transgene expression by lentivirus vectors containing second-generation tetracycline-responsive promoters.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1885813

22 September 2017

Increased levels of urokinase plasminogen activator receptor in prostate cancer cells derived from repeated metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1885813

22 September 2017

Structure-function relationships in the interaction between the urokinase-type plasminogen activator and its receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1885813

22 September 2017

Latest developments and in vivo use of the Tet system: ex vivo and in vivo delivery of tetracycline-regulated genes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1885813

22 September 2017

Transcriptional activation by tetracyclines in mammalian cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1885813

22 September 2017

Characterization of human endothelial cell urokinase-type plasminogen activator receptor protein and messenger RNA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1885813

22 September 2017

Bcl-xL promotes metastasis of breast cancer cells by induction of cytokines resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1885813

25 September 2017

Urokinase receptor antibody can reduce tumor volume and detect the presence of occult tumor metastases in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1885813

17 June 2018

Prostate cancer cells show elevated urokinase receptor in a mouse model of metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1885813

20 August 2018

RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1885813

20 August 2018

Inhibition of urokinase-type plasminogen activator receptor induces apoptosis in melanoma cells by activation of p53

1 reference

https://pubmed.ncbi.nlm.nih.gov/17509140

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1476-4598-6-34

1 reference

Europe PubMed Central

PMC publication ID

17 September 2017

Dimensions Publication ID

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/1476-4598-6-34

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40131728&oldid=2203430078"